BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9858820)

  • 21. [Chromosome banding analysis of peripheral blood lymphocytes stimulated with IL2 and CpG oligonucleotide DSP30 in patients with chronic lymphocytic leukemia].
    Stěpanovská K; Vaňková G; Némethová V; Tomášiková L; Smuhařová P; Divíšková E; Vallová V; Kuglík P; Plevová K; Oltová A; Doubek M; Pospíšilová S; Mayer J
    Klin Onkol; 2013; 26(4):263-70. PubMed ID: 23961857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
    Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance.
    Koski T; Karhu R; Visakorpi T; Vilpo L; Knuutila S; Vilpo J
    Eur J Haematol; 2000 Jul; 65(1):32-9. PubMed ID: 10914937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Liaw FP; Lau LC; Lim AS; Lim TH; Lee GY; Tien SL
    Int J Hematol; 2014 Dec; 100(6):545-53. PubMed ID: 25301672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia. a study of 40 early-onset patients.
    Doneda L; Montillo M; Intropido L; Tedeschi A; Morra E; Larizza L
    Cancer Genet Cytogenet; 2003 Jan; 140(1):31-6. PubMed ID: 12550755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous proliferative effect of tumor necrosis factor-alpha and lymphotoxin on mitogen-activated B cells from B-chronic lymphocytic leukemia.
    Alvarez-Mon M; Garcia-Suarez J; Prieto A; Manzano L; Reyes E; Lorences C; Peraile G; Jorda J; Durantez A
    Am J Hematol; 1993 Jun; 43(2):81-5. PubMed ID: 8342555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia.
    Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
    Onkologie; 2001 Feb; 24(1):60-5. PubMed ID: 11441283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosomal abnormality limited to T4 lymphocytes in a patient with T-cell chronic lymphocytic leukaemia.
    Larramendy ML; Peltomäki P; Salonen E; Knuutila S
    Eur J Haematol; 1990 Jul; 45(1):52-9. PubMed ID: 1974208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal chromosomal changes in chronic lymphocytic leukemia.
    Nayak BN; Sokal J; Ray M
    Cancer Lett; 1990 Feb; 49(2):99-105. PubMed ID: 2306714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.
    Struski S; Gervais C; Helias C; Herbrecht R; Audhuy B; Mauvieux L
    Leukemia; 2009 Mar; 23(3):617-9. PubMed ID: 18830262
    [No Abstract]   [Full Text] [Related]  

  • 33. Chromosome abnormalities in chronic lymphocytic leukemia revealed by TPA as a mitogen.
    Callen DF; Ford JH
    Cancer Genet Cytogenet; 1983 Sep; 10(1):87-93. PubMed ID: 6883302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.
    Alhourani E; Aroutiounian R; Harutyunyan T; Glaser A; Schlie C; Pohle B; Liehr T
    J Histochem Cytochem; 2016 Aug; 64(8):495-501. PubMed ID: 27315825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.
    Rigolin GM; del Giudice I; Formigaro L; Saccenti E; Martinelli S; Cavallari M; Lista E; Tammiso E; Volta E; Lupini L; Bassi C; Bardi A; Sofritti O; Daghia G; Cavazzini F; Marinelli M; Tavolaro S; Guarini A; Negrini M; Foà R; Cuneo A
    Genes Chromosomes Cancer; 2015 Dec; 54(12):818-26. PubMed ID: 26355802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of tetradecanoylphorbol acetate-stimulated peripheral blood cells enhances the prognostic value of interphase fluorescence in situ hybridization in patients with chronic lymphocytic leukemia.
    Delgado J; Aventin A; Briones J; Sanchez J; Nomdedeu J; Sierra J
    Genes Chromosomes Cancer; 2010 Apr; 49(4):327-32. PubMed ID: 20033916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
    Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
    Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
    Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
    Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic studies in seventy-six cases of B-chronic lymphoproliferative disorders.
    Solé F; Woessner S; Pérez-Losada A; Florensa L; Montero S; Asensio A; Besses C; Sans-Sabrafen J
    Cancer Genet Cytogenet; 1997 Feb; 93(2):160-6. PubMed ID: 9078302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.